An update in clinical utilization of photodynamic therapy for lung cancer
| Autor: | Janak L. Pathak, Boxin Yu, Kai Wang |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Oncology
medicine.medical_specialty medicine.medical_treatment 030303 biophysics Photodynamic therapy Review cancer treatment 03 medical and health sciences 0302 clinical medicine Internal medicine medicine In patient Lung cancer 0303 health sciences Chemotherapy Lung business.industry medicine.disease Radiation therapy lung cancer Clinical research medicine.anatomical_structure 030220 oncology & carcinogenesis Cancer cell inoperable cancer business |
| Zdroj: | Journal of Cancer |
| ISSN: | 1837-9664 |
| DOI: | 10.7150/jca.51537 |
| Popis: | Lung cancer is one of the leading causes of cancer-related death worldwide, with nearly 1.8 million-diagnosis and 1.59 million deaths. Surgery, radiotherapy, and chemotherapy in individual or combination are commonly used to treat lung cancers. Photodynamic therapy (PDT) is a highly selective method for the destruction of cancer cells by exerting cytotoxic activity on malignant cells. PDT has been the subject of numerous clinical studies and has proven to be an effective strategy for cancer therapy. Clinical studies revealed that PDT could prolong survival in patients with inoperable cancers and significantly improve quality of life. For inoperable lung cancer cases, PDT could be an effective therapy. Despite the clinical success reported, PDT is still currently underutilized to treat lung cancer and other tumors. PTD is still a new treatment approach for lung cancer mainly due to the lack of enough clinical research evaluating its' effectiveness and side effects. In this review, we discuss the current prospects and future potentials of PDT in lung cancer treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|